The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
COVID-19–related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids
Open accessAbstract
Abstract Rationale Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). ACE2 (angiotensin-converting enzyme 2), and TMPRSS2 (transmembrane protease serine 2) mediate viral infection of host cells. We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for COVID-19 morbidity. Objectives To determine the relationship between demographic features and sputum ACE2 and TMPRSS2 gene expression in asthma. Methods We analyzed gene expression for ACE2 and TMPRSS2, and for ICAM-1 (intercellular adhesion molecule 1) (rhinovirus receptor as a comparator) in sputum cells from 330 participants in SARP-3 (Severe Asthma Research Program-3) and 32 healthy control subjects. Measurements and Main Results Gene expression of ACE2 was lower than TMPRSS2, and expression levels of both genes were similar in asthma and health. Among patients with asthma, male sex, African American race, and history of diabetes mellitus were associated with higher expression of ACE2 and TMPRSS2. Use of inhaled corticosteroids (ICS) was associated with lower expression of ACE2 and TMPRSS2, but treatment with triamcinolone acetonide did not decrease expression of either gene. These findings differed from those for ICAM-1, where less consistent differences in gene expression were observed related to sex, race, and use of ICS. Conclusions Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes. The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
HISAT: a fast spliced aligner with low memory requirements
Kim, D., Langmead, B., & Salzberg, S. L. (2015) · Nature Methods · doi:10.1038/nmeth.3317 · Cited by 24,112
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020) · Science · doi:10.1126/science.abb2762 · Cited by 5,040
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926 · cited 3×
“Baseline data collection included documentation of asthma medication use, including documentation of inhaled corticosteroid (ICS) dosing consistent with European Respiratory Society/American Thoracic Society guidelines for no ICS, low/medium dose ICS, or high-dose ICS (7).”
MethodSelf-citationSkewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads
Jiang, H., Lei, R., Ding, S.-W., & Zhu, S. (2014) · BMC Bioinformatics · doi:10.1186/1471-2105-15-182 · Cited by 1,521
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Role of viral respiratory infections in asthma and asthma exacerbations
Busse, W. W., Lemanske, R. F., & Gern, J. E. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61380-3 · Cited by 750
Angiotensin-converting enzyme 2 in lung diseases
KUBA, K., IMAI, Y., & PENNINGER, J. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.03.001 · Cited by 401
Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma
Peters, M. C., Mekonnen, Z. K., Yuan, S., Bhakta, N. R., Woodruff, P. G., & Fahy, J. V. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.036 · Cited by 342
Self-citationMcNeish, D., & Kelley, K. (2019) · Psychological Methods · doi:10.1037/met0000182 · Cited by 336
Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age
Teague, W. G., Phillips, B. R., Fahy, J. V., Wenzel, S. E., Fitzpatrick, A. M., Moore, W. C., Hastie, A. T., Bleecker, E. R., Meyers, D. A., Peters, S. P., et al. (2018) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.05.032 · Cited by 280
Self-citationLiu, J., Ji, H., Zheng, W., Wu, X., Zhu, J. J., Arnold, A. P., & Sandberg, K. (2010) · Biology of Sex Differences · doi:10.1186/2042-6410-1-6 · Cited by 246
Peters, M. C., Kerr, S., Dunican, E. M., Woodruff, P. G., Fajt, M. L., Levy, B. D., Israel, E., Phillips, B. R., Mauger, D. T., Comhair, S. A., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.12.1009 · Cited by 188
Self-citationA Transcriptomic Method to Determine Airway Immune Dysfunction in T2-High and T2-Low Asthma
Peters, M. C., Ringel, L., Dyjack, N., Herrin, R., Woodruff, P. G., Rios, C., O’Connor, B., Fahy, J. V., & Seibold, M. A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1291oc · Cited by 151
Self-citationRhinoviruses and Their Receptors
Basnet, S., Palmenberg, A. C., & Gern, J. E. (2019) · CHEST Journal · doi:10.1016/j.chest.2018.12.012 · Cited by 127
Comparison of two methods of collecting induced sputum in asthmatic subjects
Gershman, N. H., Wong, H., Liu, J., Mahlmeister, M. J., & Fahy, J. V. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09122448 · Cited by 126
Self-citationAssociations Between Hypertension and Genes in the Renin-Angiotensin System
Zhu, X., Chang, Y.-P. C., Yan, D. L. S., Weder, A. B., Cooper, R., Luke, A., Kan, D., & Chakravarti, A. (2003) · Hypertension · doi:10.1161/01.hyp.0000068681.69874.cb · Cited by 125
Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma
Phipatanakul, W., Mauger, D. T., Sorkness, R. L., Gaffin, J. M., Holguín, F., Woodruff, P. G., Ly, N. P., Bacharier, L. B., Bhakta, N. R., Moore, W. C., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1453oc · Cited by 106
Self-citationBianco, A., Sethi, S., Allen, J., Knight, R. A., & Spiteri, M. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12030619 · Cited by 74
Henderson, S. O., Haiman, C. A., & Mack, W. J. (2004) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200411000-00006 · Cited by 56
A HAPLOTYPE OF THE ANGIOTENSINOGEN GENE IS ASSOCIATED WITH HYPERTENSION IN AFRICAN AMERICANS
Kumar, A., Li, Y., Patil, S., & Jain, S. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04217.x · Cited by 29
Cited by
Mechanisms of SARS-CoV-2 entry into cells
Jackson, C. B., Farzan, M., Chen, B., & Choe, H. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00418-x · Cited by 3,022
Halpin, D. M. G., Criner, G. J., Papi, A., Singh, D., Anzueto, A., Martinez, F. J., Agusti, A. A., & Vogelmeier, C. F. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3533so · Cited by 760
Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality
Zhang, J.-J., Dong, X., Liu, G.-H., & Gao, Y.-D. (2022) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-022-08921-5 · Cited by 715
ACE2: The Major Cell Entry Receptor for SARS-CoV-2
Scialo, F., Daniele, A., Amato, F., Pastore, L., Matera, M. G., Cazzola, M., Castaldo, G., & Bianco, A. (2020) · Lung · doi:10.1007/s00408-020-00408-4 · Cited by 481
Chowdhury, N. U., Guntur, V. P., Newcomb, D. C., & Wechsler, M. E. (2021) · European Respiratory Review · doi:10.1183/16000617.0067-2021 · Cited by 440
Metadata
- Authors
- Peters, M. C., Sajuthi, S., Deford, P., Christenson, S., Rios, C. L., Montgomery, M. T., Woodruff, P. G., Mauger, D. T., Erzurum, S. C., Johansson, M. W., Denlinger, L. C., Jarjour, N. N., Castro, M., Hastie, A. T., Moore, W., Ortega, V. E., Bleecker, E. R., Wenzel, S. E., Israel, E., Levy, B. D., Seibold, M. A., & Fahy, J. V.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-07-01
- Volume
- 202
- Issue
- 1
- Pages
- 83-90
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W3018108347
- Cited by
- 447
- References
- 25
- FWCI
- 50.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.